To determine whether RASAL1 manipulates ovarian adenocarcinoma progression, we evaluated the activation of key signaling proteins in the MAPK signaling pathway, including p-ERK and p-MEK. The gene discussed is MAP2K7; the disease is ovarian adenocarcinoma.